Company Filing History:
Years Active: 2011-2013
Title: Innovations by Katsuki Naitoh
Introduction
Katsuki Naitoh is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 4 patents to his name, Naitoh's work has the potential to impact medical treatments significantly.
Latest Patents
One of Naitoh's latest patents is an anti-platelet membrane glycoprotein VI monoclonal antibody. This invention provides an antibody that specifically binds to human platelet membrane glycoprotein VI (GPVI). The antibody has low activation functions for platelets and can induce thrombocytopenia in vivo. Additionally, it partially depletes GPVI on the platelet membrane by contacting with a platelet. This innovative approach could lead to advancements in therapies for various blood-related conditions.
Career Highlights
Katsuki Naitoh is currently associated with Mochida Pharmaceutical Co., Ltd., where he continues to work on groundbreaking research. His expertise in monoclonal antibodies has positioned him as a key figure in the pharmaceutical industry. Naitoh's dedication to innovation is evident in his ongoing projects and research endeavors.
Collaborations
Naitoh collaborates with notable colleagues, including Yoshitaka Hosaka and Motoyasu Honda. Their combined expertise fosters a productive research environment, leading to advancements in their respective fields.
Conclusion
Katsuki Naitoh's contributions to biotechnology, particularly through his patents, highlight his role as an influential inventor. His work on monoclonal antibodies has the potential to revolutionize medical treatments and improve patient outcomes.